
The 600-unit annual rate, if sustained, implies a stockpile target of 3,000-4,000 missiles over a 5-7 year acquisition window — comparable to the LRASM ramp-up the Navy began in 2024. If both programs are real and parallel, the Navy is hedging against two anti-ship mission sets: long-range standoff (LRASM from P-8) and stealth-penetrating strike (AESM from B-2).
This splits the industrial base and raises unit costs on both programs. The constraint isn't funding — it's fabrication floor space. Raytheon's Tucson facility is already at 85% utilization on THAAD production (per the $35B June contract); Northrop's Linthicum plant is committed to LRASM.
Either contractor will need to negotiate a third production site or accept 36-month delivery delays.
A 600-unit annual production target would require either a new production line or significant capacity reallocation at an existing missile manufacturer — and the timing exposes a hard constraint on the Navy's anti-ship doctrine.
If NAVAIR confirms this requirement in a formal RFQ by Q4 2026, the winning contractor will need 18-24 months to tool up, meaning deliveries don't begin until late 2028 at earliest. That window matters: the Navy is simultaneously accelerating LRASM integration onto P-8 Poseidon and now signaling demand for AESM on B-2s, which means two separate air-launched anti-ship missile programs are competing for the same industrial base. Watch whether RTX (Raytheon Missiles & Fire Control) or Northrop Grumman submits a proposal — and whether they bid a standalone AESM line or try to cross-load it onto existing Tomahawk or LRASM production.
Has the Navy formally quantified the operational requirement behind the 600-unit target, or is this a capability probe to test industry appetite? And does the 600-unit figure represent total inventory requirement or annual sustainment demand?
Strategic intelligence, synthesized daily — with a public track record. Every call graded against what actually happened.